S. Hegewisch Becker
Eppendorf (Germany)(DE)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, HIV Research and Treatment, Cancer Immunotherapy and Biomarkers, HIV/AIDS drug development and treatment
Most-Cited Works
- → Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells(2009)263 cited
- → Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial(2018)15 cited
- → LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)(2021)10 cited
- → A randomized, double-blind, multi-center phase III study evaluating paclitaxel with and without RAD001 in patients with gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)(2017)3 cited
- → Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial(2016)2 cited
- → 1499TiP FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab for taxane-pretreated patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction as second-line therapy – The phase II/III RAMIRIS study(2020)1 cited
- Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.(1986)
- Development of a policy for patients receiving neuromuscular blocking agents.(1998)
- → Prognosis and outcome of intensive care for very elderly patients(2015)
- → Clinical practice observation of trastuzumab (TRA) in patients (pts) with HER2-positive metastatic adenocarcinoma of the stomach (mGC) or the gastro-oesophageal junction (GEJ): Final analysis from the German non-interventional study HerMES(2017)